Anavex Life Sciences Corp (AVXL)

[abew4me]

That chart has nothing to do with FDA regs. It is showing an independent study for EB and how they are approaching a repurposed drug.

Furthermore, after reading the article, it states the following:

Initially a trial may only be carried out on a small number of people in case there are unforeseen side effects. If a phase 1 trial shows a new treatment is safe, it can be trialled on people with symptoms in a phase 2 trial. This stage can be skipped if a treatment already in use for another condition is being considered as it will already have been shown to be safe to use. This is called drug repurposing and is an important part of our research strategy as it has the potential to provide effective treatments more quickly to families living with EB.